Literature DB >> 20298369

Stable bronchiectasis is associated with low serum L-ficolin concentrations.

David Chalmers Kilpatrick1, James Duncan Chalmers, Shirley Lynn MacDonald, Maeve Murray, Ali Mohammed, Simon Paul Hart, Misao Matsushita, Adam Hill.   

Abstract

BACKGROUND AND AIMS: Bronchiectasis is a common chronic respiratory condition with recurrent cough and sputum production and recurrent chest infections. It is characterised by pathological dilatation of the bronchi thought to result from infection and inflammation. It was hypothesised that impaired innate immunity might influence susceptibility to this disease process. The aim of the present study was to look for an association between bronchiectasis and insufficiency of either mannan-binding lectin (MBL) or L-ficolin.
MATERIALS AND METHODS: MBL and L-ficolin were measured by Enzyme-linked Immunosorbent Assay (ELISA) in sera from 119 clinically stable bronchiectasis patients, and compared with 43 age-matched disease controls admitted to hospital with community-acquired pneumonia, as well as healthy blood donors (168 for L-ficolin and 564 for MBL).
RESULTS: Average (mean and median) serum L-ficolin concentrations were lower in the bronchiectasis patients (P < 0.04), but average MBL values did not differ significantly between the three groups. Relative L-ficolin deficiency was more frequent in bronchiectasis patients compared with blood donors (P <or= 0.002), whereas MBL insufficiency was associated with pneumonia.
CONCLUSION: A relative lack of serum L-ficolin might predispose to the development of bronchiectasis, although other explanations for the observed association are possible.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20298369     DOI: 10.1111/j.1752-699X.2008.00105.x

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  17 in total

Review 1.  Ficolins and infectious diseases.

Authors:  Yushan Ren; Quanquan Ding; Xiaolian Zhang
Journal:  Virol Sin       Date:  2014-01-21       Impact factor: 4.327

Review 2.  Fibrinogen-Related Proteins in Tissue Repair: How a Unique Domain with a Common Structure Controls Diverse Aspects of Wound Healing.

Authors:  Lorena Zuliani-Alvarez; Kim S Midwood
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-05-01       Impact factor: 4.730

3.  Low ficolin-2 levels in common variable immunodeficiency patients with bronchiectasis.

Authors:  M-L Metzger; I Michelfelder; S Goldacker; K Melkaoui; J Litzman; D Guzman; B Grimbacher; U Salzer
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

4.  Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia.

Authors:  A Halmos; J Rigó; J Szijártó; G Füst; Z Prohászka; A Molvarec
Journal:  Clin Exp Immunol       Date:  2012-07       Impact factor: 4.330

Review 5.  The Role of Glycosylation in Infectious Diseases.

Authors:  Xiao-Lian Zhang; Haoran Qu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

6.  No Strong Relationship Between Components of the Lectin Pathway of Complement and Susceptibility to Pulmonary Tuberculosis.

Authors:  James D Chalmers; Misao Matsushita; David C Kilpatrick; Adam T Hill
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

7.  Heparin-coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule ficolin-2 of the lectin complement pathway in vivo.

Authors:  E Hein; L Munthe-Fog; A S Thiara; A E Fiane; T E Mollnes; P Garred
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

8.  Serum ficolin-2 in hospitalised patients with community-acquired pneumonia.

Authors:  James D Chalmers; Gilly B Fleming; Julia Rutherford; Misao Matsushita; David C Kilpatrick; Adam T Hill
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 9.  Human L-ficolin (ficolin-2) and its clinical significance.

Authors:  David C Kilpatrick; James D Chalmers
Journal:  J Biomed Biotechnol       Date:  2012-02-28

Review 10.  The emerging role of complement lectin pathway in trypanosomatids: molecular bases in activation, genetic deficiencies, susceptibility to infection, and complement system-based therapeutics.

Authors:  Ingrid Evans-Osses; Iara de Messias-Reason; Marcel I Ramirez
Journal:  ScientificWorldJournal       Date:  2013-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.